Royal Bank of Canada’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$169K Sell
1,599
-1,584
-50% -$140K ﹤0.01% 4802
2025
Q4
$278K Sell
3,183
-66,813
-95% -$5.47M ﹤0.01% 4553
2025
Q3
$4.65M Sell
69,996
-4,738
-6% -$269K ﹤0.01% 2738
2025
Q2
$4.13M Buy
74,734
+64,770
+650% +$3.11M ﹤0.01% 2720
2025
Q1
$482K Buy
9,964
+2,334
+31% +$97.8K ﹤0.01% 4033
2024
Q4
$295K Sell
7,630
-5,933
-44% -$259K ﹤0.01% 4491
2024
Q3
$610K Buy
13,563
+3,341
+33% +$135K ﹤0.01% 3943
2024
Q2
$354K Buy
10,222
+4,543
+80% +$133K ﹤0.01% 4290
2024
Q1
$165K Sell
5,679
-11,776
-67% -$320K ﹤0.01% 4846
2023
Q4
$400K Buy
17,455
+9,396
+117% +$164K ﹤0.01% 4463
2023
Q3
$134K Buy
8,059
+3,842
+91% +$74.5K ﹤0.01% 5154
2023
Q2
$116K Buy
4,217
+1,583
+60% +$39.6K ﹤0.01% 5213
2023
Q1
$61K Sell
2,634
-2,909
-52% -$48.9K ﹤0.01% 5517
2022
Q4
$60K Buy
5,543
+4,732
+583% +$39.9K ﹤0.01% 5773
2022
Q3
$7K Buy
811
+301
+59% +$2.85K ﹤0.01% 6607
2022
Q2
$4K Sell
510
-2,490
-83% -$30.1K ﹤0.01% 6751
2022
Q1
$71K Sell
3,000
-7,067
-70% -$199K ﹤0.01% 5864
2021
Q4
$345K Buy
10,067
+5,282
+110% +$167K ﹤0.01% 4808
2021
Q3
$85K Buy
4,785
+1,455
+44% +$62K ﹤0.01% 5825
2021
Q2
$149K Buy
3,330
+6
+0.2% +$198 ﹤0.01% 5317
2021
Q1
$86K Buy
3,324
+2,134
+179% +$54K ﹤0.01% 5558
2020
Q4
$24K Buy
1,190
+690
+138% +$14.8K ﹤0.01% 5983
2020
Q3
$10K Hold
500
﹤0.01% 5926
2020
Q2
$9K Buy
500
+448
+862% +$5.62K ﹤0.01% 5872
2020
Q1
$0 Sell
52
-1,050
-95% -$7.87K ﹤0.01% 6951
2019
Q4
$8K Buy
+1,102
New +$10.9K ﹤0.01% 6225
2019
Q1
Sell
-500
Closed -$3K 7034
2018
Q4
$3K Sell
500
-7
-1% -$56 ﹤0.01% 6349
2018
Q3
$5K Buy
507
+107
+27% +$921 ﹤0.01% 6272
2018
Q2
$3K Buy
400
+220
+122% +$1.69K ﹤0.01% 6176
2018
Q1
$2K Buy
180
+109
+154% +$2.05K ﹤0.01% 6119
2017
Q4
$1K Sell
71
-687
-91% -$12.2K ﹤0.01% 6410
2017
Q3
$13K Buy
758
+706
+1,358% +$9.78K ﹤0.01% 6175
2017
Q2
$1K Sell
52
-191
-79% -$2.04K ﹤0.01% 6425
2017
Q1
$3K Sell
243
-114
-32% -$1.84K ﹤0.01% 6361
2016
Q4
$8K Buy
357
+157
+79% +$3.5K ﹤0.01% 6163
2016
Q3
$4K Buy
+200
New +$2.73K ﹤0.01% 6035

Other funds holding PTGX